Lucefi OD film 2.5 mg for type 2 diabetic mellitus (luseoglifozin)

Is Lucefi OD film 2.5 mg effective for type 2 diabetic mellitus (luseoglifozin)?

 

Managing type 2 diabetes mellitus requires an effective solution that not only controls blood sugar levels but also provides additional health benefits. Lucefi OD film is a modern and convenient option for individuals looking for reliable diabetes treatment. Powered by Luseogliflozin, an SGLT2 inhibitor developed by Taisho Pharmaceutical, this medication helps regulate blood glucose levels by promoting the excretion of excess glucose through urine.

 

Why Choose Lucefi OD Film for Diabetes Treatment?

 

Lucefi OD film offers multiple advantages over traditional diabetes tablets, making it a preferred choice for many patients.

 

Clinically Proven Safety and Efficacy

 

The effectiveness of Luseogliflozin in improving both glycemic and non-glycemic outcomes has been supported by multiple studies. A meta-analysis conducted by Dutta D, Kadian J et al. (Mar 2023) in Diabetes Metab Syndr highlighted its safety, showing no significant association with severe adverse events or genital infections. The recommended dose of 2.5–5 mg daily has demonstrated reliable results in managing type 2 diabetes while minimizing side effects.

Take control of your diabetes management with Lucefi OD film and experience a more convenient and effective way to maintain your health.

 

Package details: 100 sheets

Dosage and administration: adults should take 1 film (2.5 mg of Luseogliflozin) at a time, once a day before or after breakfast. Your doctor may increase the dosage up to 5 mg at a time, once a day according to your symptoms. You can take this medicine without water as it will disintegrate with saliva when put on the tongue. However, you can also take it with water if you wish so.

Active components: luseogliflozin hydrate

Therapeutic effect: treatment of type 2 diabetic mellitus

Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Do not use for patients with ketosis, diabetic coma/precoma, infections, injury, pituitary gland malfunction, adrenal gland dysfunction, irregular eating habits, insufficient food intake, excessive alcohol intake, urinary tract infection or genital infection, patients in a pre- of post-operative state, poor nutritional state, starvation state, debilitated state or performing intense muscular exercise. As this medicine may cause hypoglycemia symptoms, patient should pay close attention when working at heights, operating dangerous machinery or driving a car. In case of hypoglycemia symptoms, patient should immediately take sugar (sugar, candy, juice, glucose, etc.) or glucose (for patients taking alpha-glucosidase inhibitor). Patient should drink an adequate amount of water to avoid dehydration. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.